CNBC’s Jim Cramer on Wednesday told investors the Trump administration is more likely to allow mergers and acquisitions to go ...

CNBC’s Jim Cramer explained that few sectors are currently obvious winners or losers under either candidate’s administration.

CNBC’s Jim Cramer on Monday told investors not to write off the power of European markets, pointing out economic growth ...

CNBC’s Jim Cramer on Election Day identified stocks that could perform well with either presidential candidate in the White House.

We recently published a list of Jim Cramer November Portfolio: Top 10 Stocks. In this article, we are going to take a look at ...

We recently published a list of Jim Cramer November Portfolio: Top 10 Stocks. In this article, we are going to take a look at ...

Some health experts say Kennedy, even in an informal role, could potentially lead to real consequences for patients, ...

Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom Broadcom expanded its multi-year partnership with Telia Company to advance telecom and cloud infrastructure using VMware's product portfolio.

David Risinger has given his Hold rating due to a combination of factors, primarily revolving around Pfizer’s development of ponsegromab. This monoclonal antibody, designed to treat cachexia by ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Aamir Malik, Chief U.S. Commercial Officer ...

NEW YORK, November 04, 2024--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Aamir Malik, Chief U.S ...

Few companies embody the term 'pharma giant' as much as Pfizer. Here we take a look at the colourful history of one of the biggest drugmakers in the world. Pfizer was founded in 1849 by two recent ...